Indefinite Delivery Contract 75N94023D00006
Award Date
9/26/23
Last Date to Order
9/25/28
Federal Agency
National Institute of Child Health and Human Development
Awardee
Sri International
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Pricing Type
Cost Plus Fixed Fee
Legislative Mandate
Clinger Cohen Act
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The National Institutes of Health's Eunice Kennedy Shriver National Institute of Child Health and Human Development awarded an Indefinite Delivery Contract to Sri International to establish a Biological Testing Facility. The contract has a potential value of $40,000,000 over a five-year base period and four option years from August 2020 to August 2025.
The Biological Testing Facility provides state-of-the-art preclinical evaluation capabilities to assess new compounds, formulations, delivery...
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded Sri International a multiple award indefinite delivery contract to provide resources advancing pediatrics and HIV prevention science. Valued at up to $98.8 million over seven years, the contract aims to support preclinical gap filling, animal model studies, bioanalytical services, product manufacturing, and scientific/quality assistance.
Sri International has also received a $45,041 delivery order...
This federal contract IDV was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services (HHS), to SRI International, a non-profit research and development institute. The IDV has a ceiling value of $20,011,859 and does not have any set-aside designations. It provides a vehicle for NICHD to efficiently procure a wide range of scientific, engineering, and technical services from SRI International,...
This indefinite delivery contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Sri International, a non-profit research institute. The $3.9 million contract supports NCATS' drug development programs by (1) developing and validating sensitive bioanalytical methods to quantify concentrations of novel biologics, (2) developing assays to measure anti-drug antibodies, and (3)...
This indefinite delivery contract was awarded by the National Cancer Institute, a component of the U.S. Department of Health and Human Services, to the non-profit research and development institute SRI International. The single-award contract, valued at a ceiling of $12,069,385, is for the analysis and synthesis of GMP and non-GMP bulk drugs and pharmaceutical formulations. With a period of performance running through April 2028, this contract enables the National Cancer Institute to...
The National Cancer Institute awarded Sri International a multiple award indefinite delivery contract to provide research and development services supporting preclinical pharmacokinetic and pharmacology evaluations of agents for cancer patients. The contract has a potential value of $9.9 million and a period of performance through September 2028.
Under the contract, Sri International will implement and validate analytical methodologies to quantify compounds from biological fluids and tissues...
The National Institutes of Health (NIH), through its National Institute on Drug Abuse (NIDA), has awarded a Basic Ordering Agreement (BOA) contract to Sri International, a nonprofit research and development institute. The purpose of this $9.75 million, single-award IDV contract is to conduct toxicological evaluations of potential medications to support NIDA's drug abuse research program.
Under this IDV, NIDA has issued several cost-plus-fixed-fee task orders to Sri International, valued at...
The National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract to Sri International to provide preclinical development support for candidate products and drug development activities. The $107.3M contract has a 7-year period of performance from October 2020 to October 2027.
The contract encompasses a broad scope of work, including in vitro testing and screening,...
This Indefinite Delivery Contract (IDC) with a ceiling value of $342,897 was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, to the non-profit research and development organization SRI International. The contract is for the provision of IN VITRO METABOLISM AND NON-CLINICAL ADME STUDIES, with a period of performance from September 27, 2021 to September 26, 2026. The initial task order under this IDC was awarded in the...
The National Institutes of Health's National Institute of Child Health and Human Development awarded Oregon Health & Science University an indefinite delivery contract with a potential value of $5,000,000 to conduct clinical trials in support of contraceptive development. Task orders issued against this contract include protocols for Phase 1 evaluation of the Ovaprene device ($181k), central laboratory services for pharmacokinetic analysis of levonorgestrel butanoate ($349k), and...